GeneDx Holdings Corp. (WGSWW)

Market Cap	2.62B +36.3%
Revenue (ttm)	402.19M +50.5%
Net Income	2.08M
EPS	0.07
Shares Out	28.90M
PE Ratio	1,258.31
Forward PE	193.44
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,200
Open	0.0143
Previous Close	0.0169
Day's Range	0.0137 - 0.0166
52-Week Range	0.0136 - 0.3410
Beta	2.02
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 23, 2026

About WGSWW

GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut.

• Industry: Medical - Healthcare Information Services
• Sector: Healthcare
• Founded: 2017
• Employees: 1,000
• Stock Exchange: NASDAQ
• Ticker Symbol: WGSWW
• Website: https://www.genedx.com